Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #301 to #550.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Rehabilitation of living conditions‏‎ (2 revisions)
  2. Right to know‏‎ (2 revisions)
  3. Incidence‏‎ (2 revisions)
  4. Containment‏‎ (2 revisions)
  5. Solar wind‏‎ (2 revisions)
  6. Target tissue‏‎ (2 revisions)
  7. Dose-length product‏‎ (2 revisions)
  8. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  9. Working level‏‎ (2 revisions)
  10. OLINDA/EXM‏‎ (2 revisions)
  11. Equieffective dose‏‎ (2 revisions)
  12. Particle radiance‏‎ (2 revisions)
  13. Expanded and aligned radiation field‏‎ (2 revisions)
  14. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  15. Radiosensitivity, cellular‏‎ (2 revisions)
  16. Hypoplasia‏‎ (2 revisions)
  17. Backscatter detection system‏‎ (2 revisions)
  18. Bradycardia‏‎ (2 revisions)
  19. Rigidity‏‎ (2 revisions)
  20. Security‏‎ (2 revisions)
  21. Incident‏‎ (2 revisions)
  22. Intermediate level waste‏‎ (2 revisions)
  23. Stenosis‏‎ (2 revisions)
  24. Detriment‏‎ (2 revisions)
  25. Local DRL‏‎ (2 revisions)
  26. Dose-rate effect‏‎ (2 revisions)
  27. Tolerability‏‎ (2 revisions)
  28. Medical exposure‏‎ (2 revisions)
  29. Naturally occurring radioactive material‏‎ (2 revisions)
  30. Electron-capture decay‏‎ (2 revisions)
  31. Working level month‏‎ (2 revisions)
  32. Potential recoverability correction factor‏‎ (2 revisions)
  33. Accreditation‏‎ (2 revisions)
  34. Protective action guide‏‎ (2 revisions)
  35. Genomic integrity‏‎ (2 revisions)
  36. Radiation worker‏‎ (2 revisions)
  37. Hazard‏‎ (2 revisions)
  38. Bragg peak‏‎ (2 revisions)
  39. Inclusiveness‏‎ (2 revisions)
  40. Coronary heart disease‏‎ (2 revisions)
  41. Source-related‏‎ (2 revisions)
  42. Internal conversion electron‏‎ (2 revisions)
  43. Decay constant‏‎ (2 revisions)
  44. LD 50/30‏‎ (2 revisions)
  45. Telangiectasia‏‎ (2 revisions)
  46. Member of the public‏‎ (2 revisions)
  47. Dose of record Hp (10)‏‎ (2 revisions)
  48. Unattached fraction‏‎ (2 revisions)
  49. Necrosis‏‎ (2 revisions)
  50. Electrophysiology‏‎ (2 revisions)
  51. Patient entrance reference point‏‎ (2 revisions)
  52. Peak skin dose‏‎ (2 revisions)
  53. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  54. Action Level‏‎ (2 revisions)
  55. Radioactive dispersion device‏‎ (2 revisions)
  56. Health Surveillance‏‎ (2 revisions)
  57. Radon: Units of Measure‏‎ (2 revisions)
  58. Basal cell‏‎ (2 revisions)
  59. Reference air kerma‏‎ (2 revisions)
  60. Branching fraction‏‎ (2 revisions)
  61. Chronic exposure‏‎ (2 revisions)
  62. Colony‏‎ (2 revisions)
  63. Self-help protection‏‎ (2 revisions)
  64. Individual-related‏‎ (2 revisions)
  65. Cosmic Radiation in Aviation‏‎ (2 revisions)
  66. Decommissioning‏‎ (2 revisions)
  67. Storage‏‎ (2 revisions)
  68. Dose-threshold‏‎ (2 revisions)
  69. Track structure‏‎ (2 revisions)
  70. Mendelian diseases‏‎ (2 revisions)
  71. Neurological syndrome‏‎ (2 revisions)
  72. Occupational exposure‏‎ (2 revisions)
  73. Pelagic‏‎ (2 revisions)
  74. Exposure, external or internal‏‎ (2 revisions)
  75. Practical radiological protection culture‏‎ (2 revisions)
  76. Graft vs host disease‏‎ (2 revisions)
  77. Air-kerma, incident‏‎ (2 revisions)
  78. Radioactive source‏‎ (2 revisions)
  79. Heliosphere‏‎ (2 revisions)
  80. Class SR-0 gases‏‎ (2 revisions)
  81. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  82. Individual decontamination‏‎ (2 revisions)
  83. Decontamination‏‎ (2 revisions)
  84. Subcutaneous tissue‏‎ (2 revisions)
  85. Diastasis‏‎ (2 revisions)
  86. Low dose rate‏‎ (2 revisions)
  87. Transfer compartment‏‎ (2 revisions)
  88. Mitigation‏‎ (2 revisions)
  89. Dose per unit intake coefficient‏‎ (2 revisions)
  90. Upper reference levels‏‎ (2 revisions)
  91. Neurovascular syndrome‏‎ (2 revisions)
  92. Emergency‏‎ (2 revisions)
  93. Exposure (in the context of inhalation)‏‎ (2 revisions)
  94. Fractionation and dose delivery patterns‏‎ (2 revisions)
  95. Qualified expert‏‎ (2 revisions)
  96. Radioactive substance‏‎ (2 revisions)
  97. Reference biokinetic model‏‎ (2 revisions)
  98. Broad beam therapy irradiation technique‏‎ (2 revisions)
  99. Relocation‏‎ (2 revisions)
  100. Class SR-1 gases‏‎ (2 revisions)
  101. Risk coefficient‏‎ (2 revisions)
  102. Committed effective dose‏‎ (2 revisions)
  103. Individual monitoring‏‎ (2 revisions)
  104. Cost-benefit analysis‏‎ (2 revisions)
  105. Source term‏‎ (2 revisions)
  106. Decontamination factor‏‎ (2 revisions)
  107. Latent time/period or latency interval‏‎ (2 revisions)
  108. Low level waste‏‎ (2 revisions)
  109. Dose rate‏‎ (2 revisions)
  110. Emergency exposure situation‏‎ (2 revisions)
  111. Erythropoietin‏‎ (2 revisions)
  112. Percutaneous coronary intervention‏‎ (2 revisions)
  113. ALARA‏‎ (2 revisions)
  114. Prevailing circumstances‏‎ (2 revisions)
  115. Hierarchical tissues‏‎ (2 revisions)
  116. Area monitoring‏‎ (2 revisions)
  117. Radon Recommendations for Authorities‏‎ (2 revisions)
  118. Benthic‏‎ (2 revisions)
  119. Reference individual‏‎ (2 revisions)
  120. Bronchial region‏‎ (2 revisions)
  121. Remedial action‏‎ (2 revisions)
  122. Class SR-2 gases‏‎ (2 revisions)
  123. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  124. Committed equivalent dose‏‎ (2 revisions)
  125. Intervention Level‏‎ (2 revisions)
  126. Substantial radiation dose level‏‎ (2 revisions)
  127. Dichotomous‏‎ (2 revisions)
  128. Transfer rate‏‎ (2 revisions)
  129. Multi-detector computed tomography‏‎ (2 revisions)
  130. Dose rate effectiveness factor‏‎ (2 revisions)
  131. Emergency plan‏‎ (2 revisions)
  132. Ethics‏‎ (2 revisions)
  133. Pericarditis‏‎ (2 revisions)
  134. Principle of application of dose limits‏‎ (2 revisions)
  135. Activity‏‎ (2 revisions)
  136. Radioactivity‏‎ (2 revisions)
  137. High level waste‏‎ (2 revisions)
  138. Radon Recommendations for Workplaces‏‎ (2 revisions)
  139. Reference level‏‎ (2 revisions)
  140. Remediation‏‎ (2 revisions)
  141. Clearance‏‎ (2 revisions)
  142. Risk of Exposure to Radon‏‎ (2 revisions)
  143. South Atlantic anomaly‏‎ (2 revisions)
  144. Interventional procedure‏‎ (2 revisions)
  145. Deontological Ethics‏‎ (2 revisions)
  146. Differentiation‏‎ (2 revisions)
  147. Lymphatic system‏‎ (2 revisions)
  148. Transforming growth factor‏‎ (2 revisions)
  149. Exposure pathway‏‎ (1 revision)
  150. Functional subunits‏‎ (1 revision)
  151. Activity median aerodynamic diameter‏‎ (1 revision)
  152. Quasi-threshold dose‏‎ (1 revision)
  153. Ground-level enhancement‏‎ (1 revision)
  154. Radon progeny‏‎ (1 revision)
  155. ICRP Publication 101a‏‎ (1 revision)
  156. Reference parameter value‏‎ (1 revision)
  157. ICRP Publication 114‏‎ (1 revision)
  158. ICRP Publication 129‏‎ (1 revision)
  159. ICRP Publication 143‏‎ (1 revision)
  160. Compartment (environmental)‏‎ (1 revision)
  161. ICRP Publication 18‏‎ (1 revision)
  162. Cross section‏‎ (1 revision)
  163. ICRP Publication 30 (Part 1)‏‎ (1 revision)
  164. Deposition‏‎ (1 revision)
  165. Supervised area‏‎ (1 revision)
  166. ICRP Publication 39‏‎ (1 revision)
  167. Digital breast tomosynthesis‏‎ (1 revision)
  168. Thoron progeny‏‎ (1 revision)
  169. ICRP Publication 53‏‎ (1 revision)
  170. Transgenerational effect‏‎ (1 revision)
  171. ICRP Publication 68‏‎ (1 revision)
  172. ICRP Publication 82‏‎ (1 revision)
  173. Non-homologous end joining‏‎ (1 revision)
  174. Optimisation of protection‏‎ (1 revision)
  175. Excess absolute risk‏‎ (1 revision)
  176. Phantom‏‎ (1 revision)
  177. Homologous recombination‏‎ (1 revision)
  178. Authorised discharge‏‎ (1 revision)
  179. Ras‏‎ (1 revision)
  180. ICRP Publication 101b‏‎ (1 revision)
  181. Reference phantom‏‎ (1 revision)
  182. ICRP Publication 115‏‎ (1 revision)
  183. ICRP Publication 13‏‎ (1 revision)
  184. ICRP Publication 90‏‎ (1 revision)
  185. Clinical audit‏‎ (1 revision)
  186. ICRP Publication 144‏‎ (1 revision)
  187. Size-specific dose estimate‏‎ (1 revision)
  188. ICRP Publication 19‏‎ (1 revision)
  189. Specific absorbed fraction‏‎ (1 revision)
  190. ICRP Publication 30 (Part 2)‏‎ (1 revision)
  191. Surface contamination‏‎ (1 revision)
  192. ICRP Publication 4‏‎ (1 revision)
  193. ICRP Publication 54‏‎ (1 revision)
  194. Translocation‏‎ (1 revision)
  195. ICRP Publication 69‏‎ (1 revision)
  196. Multistage carcinogenesis model‏‎ (1 revision)
  197. ICRP Publication 83‏‎ (1 revision)
  198. Principles of protection‏‎ (1 revision)
  199. Acute exposure‏‎ (1 revision)
  200. Radiation-induced second cancer‏‎ (1 revision)
  201. Allometry‏‎ (1 revision)
  202. Rb‏‎ (1 revision)
  203. ICRP Publication 102‏‎ (1 revision)
  204. Reference value‏‎ (1 revision)
  205. ICRP Publication 116‏‎ (1 revision)
  206. ICRP Publication 130‏‎ (1 revision)
  207. ICRP Publication 91‏‎ (1 revision)
  208. ICRP Publication 145‏‎ (1 revision)
  209. Slice‏‎ (1 revision)
  210. ICRP Publication 2‏‎ (1 revision)
  211. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  212. Derived consideration reference level‏‎ (1 revision)
  213. ICRP Publication 40‏‎ (1 revision)
  214. Threshold level‏‎ (1 revision)
  215. ICRP Publication 55‏‎ (1 revision)
  216. Dose conversion convention‏‎ (1 revision)
  217. ICRP Publication 7‏‎ (1 revision)
  218. ICRP Publication 84‏‎ (1 revision)
  219. Organ at risk‏‎ (1 revision)
  220. Exclusion‏‎ (1 revision)
  221. Pilomatricoma‏‎ (1 revision)
  222. Radiation-induced secondary malignancy‏‎ (1 revision)
  223. Radiological attack‏‎ (1 revision)
  224. Reactive oxygen species‏‎ (1 revision)
  225. Biological half-life‏‎ (1 revision)
  226. Reference worker‏‎ (1 revision)
  227. ICRP Publication 117‏‎ (1 revision)
  228. ICRP Publication 131‏‎ (1 revision)
  229. ICRP Publication 92‏‎ (1 revision)
  230. ICRP Publication 146‏‎ (1 revision)
  231. Concentration ratio‏‎ (1 revision)
  232. ICRP Publication 20‏‎ (1 revision)
  233. Informed consent‏‎ (1 revision)
  234. Spongiosa‏‎ (1 revision)
  235. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  236. Derived investigation level‏‎ (1 revision)
  237. ICRP Publication 41‏‎ (1 revision)
  238. Directional dose equivalent‏‎ (1 revision)
  239. ICRP Publication 56‏‎ (1 revision)
  240. Marrow cellularity‏‎ (1 revision)
  241. Dose conversion factor‏‎ (1 revision)
  242. ICRP Publication 70‏‎ (1 revision)
  243. Multitarget equation‏‎ (1 revision)
  244. Effect modifier‏‎ (1 revision)
  245. ICRP Publication 85‏‎ (1 revision)
  246. Endosteum‏‎ (1 revision)
  247. Radiological controlled area‏‎ (1 revision)
  248. Human Alimentary Tract Model‏‎ (1 revision)
  249. ICRP Publication 104‏‎ (1 revision)
  250. Biomarker‏‎ (1 revision)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)